Lv1
40 积分 2022-11-22 加入
Safety issues in children and adolescents during growth hormone therapy—a review
2天前
已完结
Somapacitan in children born small for gestational age: a multi-centre, open-label, controlled phase 2 study
2天前
已关闭
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
3天前
已完结
Somapacitan, a once‐weekly reversible albumin‐binding GH derivative, in children with GH deficiency: A randomized dose‐escalation trial
28天前
已完结
Speeding up Antibody-Drug Conjugate Development in Pretreated EGFR-Mutant Non–Small-Cell Lung Cancer
1个月前
已完结
Antibody-Drug Conjugates for Lung Cancer: Payloads and Progress
1个月前
已完结
Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations
1个月前
已完结
Abstract PS08-07: BL-B01D1, a first-in-class EGFRxHER3 bispecific antibody-drug conjugate, in patients with Locally Advanced or Metastatic Breast Cancer and other Solid Tumor: Results from a phase 1 study
1个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
1个月前
已完结
Mutant forms of EGFR promote HER2 trafficking through efficient formation of HER2-EGFR heterodimers
1个月前
已完结
皖公网安备34019202002308
